Vibrio vulnificus was isolated from a bacteremic patient. This strain, together with other isolates of V. vulnificus, was compared with V. alginolyticus, V. fluvialis, and V. parahaemolyticus with regard to growth characteristics on enteric agar media (enabling isolation and identification) and production of exoenzymes which could correlate with invasive potential. V. vulnificus grew well on MacConkey, Endo, xylose-lysine deoxycholate, and Hektoen enteric agar plates. Because V. vulnificus colonies resembled those of lactosefermenting strains of the family Enterobacteriaceae, however, isolation of this vibrio from mixed specimens or stools may require the use of thiosulfate-citrate-bile salts-sucrose agar. V. vulnificus produced numerous exoenzymes (protease, DNase, lipase, and esterase) but not elastase or lecithinase. Although differences in exoenzyme production were observed among the four vibrio species, no single exoenzyme could be linked to the invasive potential of V. vulnificus.
Halophilic vibrios such as Vibrio alginolyticus and Vibrio parahaemolyticus are increasingly being isolated from extraintestinal sources (2) . Although these species are more often recognized as agents of ear infections or gastroenteritis, they have been isolated from leg wounds, a stump ulcer, and eyes (12, 15, 16) . Despite these reports, the clinical suggestion of the presence of a marine bacterium is often overlooked, as the symptoms of vibrio infections are often similar to those produced by agents more common than halophilic vibrios. Another obstacle to the awareness of the presence of vibrios is that these infections frequently develop in individuals after they have returned from coastal regions where they acquired the organism to inland areas where the etiological role of the organism is less appreciated (12) .
Human infection attributable to a lactose-fermenting halophilic vibrio is now beginning to draw the attention of both clinicians and microbiologists. This species, extensively investigated by Hollis and co-workers (7) and designated V. vulnificus by Farmer (5) , is genetically distinct from the biochemically similar V. parahaemolyticus and V. alginolyticus. Although V. vulnificus may also be recovered from cutaneous infections, primary septicemia is the most common clinical presentation, usually observed in individuals within 24 h after the ingestion of contaminated raw shellfish (1, 2, 9, 10, 13).
Although knowledge of the latter halophile as a human pathogen is emerging, its isolation and accurate identification, infection-associated risk factors, and invasive potential compared with those of V. alginolyticus, V. parahaemolyticus, and the more recently encountered Vibrio fluvialis (17) still remain obscure. The present report documents our study in which the cultural and enzymatic properties of a bacteremic isolate of V. vulnificus were compared with those of its halophilic counterparts. Our aim was to assess the in vitro enzymatic activity of V. vulnificus as it may relate to invasiveness. * Corresponding author.
MATERIALS AND METHODS
Source of organisms. The blood isolate of V. vulnificus was recovered from a 65-year-old patient who developed bacteremia after the ingestion of a seafood dinner which included oysters and clams. V. alginolyticus was isolated from a wound culture, and V. parahaemolyticus was isolated from the stool of a patient with gastroenteritis, which developed after the consumption of crabmeat. Five additional strains of V. vulnificus and four strains each of V. alginolyticus, V. fluvialis, and V. parahaemolyticus were obtained from Don Brenner, Centers for Disease Control, Atlanta, Ga. One strain of V. vulnificus was obtained from Timothy Overman, Veterans Administration Medical Center, Lexington, Ky. The Vibrio spp. were identified by the API 20E profile (Analytab Products, Plainview, N.Y.). Additional tests for the characterization of the V. vulnificus isolates included the determination of salt tolerance (with 1% peptone broth), starch and esculin hydrolysis, malonate fermentation, nitrate reduction, and the ability to initiate growth in the presence of sodium acetate.
Culture and biochemical reactions. The Vibrio isolates were maintained on Trypticase soy agar plates containing 5% sheep blood (BBL Microbiology Systems, Cockeysville, Md.). The colonial characteristics of each strain on various selective media were studied by dilution streaking each isolate onto xylose-lysine deoxycholate (XLD) agar, eosinmethylene blue agar, Hektoen-enteric (HE) agar, MacConkey (MC) agar, Endo agar, salmonella-shigella (SS) agar, desoxycholate (DC) agar, and thiosulfate-citrate-bile saltssucrose (TCBS) agar. Colonial morphology was assessed after 24 and 48 h of incubation. The four Vibrio species were evaluated for exoenzyme activity by spot inoculation (2 mm) onto non-saline-supplemented media containing substrates for the determination of elastase, lecithinase, lipase, protease (caseinase), and esterase activities as previously described (6, 8, 14) . Gelatinase production was determined by making a turbid suspension of the test strain in 1 ml of saline, after which a gelatin strip (Key Scientific, Los Angeles, Calif.) was added to each tube. Removal of the gelatin coat with the appearance of the blue supporting base indicated (1) . When considering halophilic vibrios as human pathogens, the remarkable invasive capability of V. vulnificus serves as a major distinguishing feature. Although comparison of the exoenzyme profiles of the four halophilic vibrios showed differences which might be useful in differentiating the four species, no particular enzyme was found that could clearly be correlated with the invasive tendency of V. vulnificus.
Recently, laboratory and animal studies have demonstrated that V. vulnificus isolates are relatively resistant to the bacterial activity of normal human serum, produce edema and hemoconcentration in infected mice, and produce a cytolytic and cytotoxic heat-labile extracellular toxin (3, 4, 11) . Whether these features can solely account for the bacteremic tendency of V. vulnificus, as demonstrated in our patient, remains to be determined.
